07-Dec-2016 - As part of its collaboration with the National Institutes of Health (NIH) in the DNA vaccine clinical trial for the Zika virus, PharmaJet is providing its Stratis Needle-Free device and training to the NIH.
News in brief
- Arrowhead fires CSO & Co-inventor of delivery tech responsible for clinical trial abandonment
- Amgen secures a wearable injector deal with Unilife
- MannKind ups Afrezza production but Sanofi says sales are modest
- Cipla buys Indian plants from contractor
- Rexam opens extension at French nasal pump plant
06-Dec-2016 - Takeda was awarded conditional EU marketing authorisation of the small molecule drug Ninlaro, overturning the EMA’s negative opinion on its efficacy against Multiple Myeloma (MM).
06-Dec-2016 - AstraZeneca has partnered with Bicycle Therapeutics in a potential $1bn deal to develop a new class of small molecules which have antibody-like properties.
News in brief
02-Dec-2016 - Arrowhead Pharmaceuticals Inc. has also laid off its Chief scientific officer David Lewis - as part of the 34 staff cull - after several trials using delivery vehicle Ex1 were stopped by the firm.
30-Nov-2016 - Arrowhead has abandoned development of therapies which use its Ex1 delivery vehicle, axing multiple clinical trials and sacking staff.
30-Nov-2016 - Delivery device with West Pharmaceutical Services has completed the expansion of its plant in Mulhuddart, County Dublin.
28-Nov-2016 - Catalent will add two Canadian manufacturing facilities to its softgel network through the acquisition of Accucaps.
23-Nov-2016 - Evonik has laid plans to expand a polymer facility in Alabama to cater for growing demand for sophisticated drug delivery and medical devices.
Drug Delivery: Featured news
Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.
On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a look at the pharma inventions Scotland gave the world.